PharmaTech Integrates 2022 Track 1
MAKING AND TAKING
Focusing on advances in manufacturing, formulation and drug delivery technologies
Welcome and opening remarks
DAVE TUDOR, Managing Director, Medicines Manufacturing Innovation Centre, CPI
Fireside Chat
MARTIN MEESON | Chief Executive Officer | FUJIFILM Diosynth Biotechnologies
Fireside Chat
MAUREEN WEDDERBURN | Non Executive Chair | Medicines Manufacturing Innovation Centre
STEVEN BAGSHAW CBE | Bio industrial Specialist and Non-Executive Director | CPI
Pro-Active Ingredients
Building on the advances in process intensification and continuous manufacturing to further enhance the efficiency and quality of active ingredients manufacturing.
FACILITATED BY
Mark Humphries | Design and Engineering Expert | PA Consulting
PANELLISTS
Jonathan Haigh | Vice President, Process Development | FUJIFILM Diosynth Biotechnologies
Robert Peeling | Technical Services Director | Britest
Jon-Paul Sherlock | Head of Innovative Manufacturing Technology | AstraZeneca
Implications of Point of Care and Distributed Manufacture
As medicines become more stratified and manufacturing runs become smaller, how should the manufacturing network change to keep up?
What structural challenges do these changes present and how can we use manufacturing innovation and digital tools, along with updated regulatory strategies, to grasp the opportunities?
FACILITATED BY
Martin Warman | Associate Member | Centre for Process Analytics and Control Technology (CPACT)
PANELLISTS
Dave Berry | Grand Challenge Lead | Medicines Manufacturing Innovation Centre
Andy Dwyer | Senior VP of CMC and Supply Chain | Summit Therapeutics
Paul Knight | Chief Executive Officer | CME Ltd
Ian Rees | Assessor – Innovation Accelerator | MHRA Science, Research and Innovation Group
Ingo Krause | Chief Executive Officer | PrivMed
Free Form Thinking
Applying the rapidly advancing knowledge and technologies for the control of physical form and formulation to enhance product application, performance and safety
FACILITATED BY
Massimo Bresciani | CMAC Industry Director | University of Strathclyde
PANELLISTS
Nathalie Huther | VP Business Development | Nanoform
Mingzhong Li | Professor of Crystallisation Science & Drug Delivery | De Montfort University
John Mykytiuk | Solid State Manager | Sterling Pharma Solutions
Special Delivery
How finished dose form technologies are advancing to deliver more efficient products, better supply chains and improved patient outcomes
PANELLISTS
Chris Van Der Walle | Edinburgh Centre Director | Cell & Gene Therapy Catapult
Ajith Kumar Perakathu Somasekharan | Founder & CEO | Intelligent Assist
Mingzhong Li | Professor of Crystallisation Science & Drug Delivery | De Montfort University
Jon-Paul Sherlock | Head of Innovative Manufacturing Technology | AstraZeneca